Cocrystal Pharma Management
Management criteria checks 3/4
Cocrystal Pharma's CEO is Sam Lee, appointed in Jan 2008, has a tenure of 16.25 years. total yearly compensation is $627.20K, comprised of 62.9% salary and 37.1% bonuses, including company stock and options. directly owns 0.36% of the company’s shares, worth $56.79K. The average tenure of the management team and the board of directors is 16.3 years and 4.5 years respectively.
Key information
Sam Lee
Chief executive officer
US$627.2k
Total compensation
CEO salary percentage | 62.9% |
CEO tenure | 16.3yrs |
CEO ownership | 0.4% |
Management average tenure | 16.3yrs |
Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Cocrystal selects its antiviral drug candidate to develop as a treatment for COVID-19
Oct 11Cocrystal Pharma GAAP EPS of -$0.25 misses by $0.21
Aug 15Cocrystal Pharma (NASDAQ:COCP) Is In A Good Position To Deliver On Growth Plans
Aug 14Cocrystal engages Open Orphan to conduct mid-stage trial of oral influenza drug in UK
Aug 08We're Not Very Worried About Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate
Mar 19Companies Like Cocrystal Pharma (NASDAQ:COCP) Are In A Position To Invest In Growth
Nov 19We Think Cocrystal Pharma (NASDAQ:COCP) Can Afford To Drive Business Growth
Aug 06Cocrystal’s soars 11% as CDI-45205 shows excellent antiviral activity against SARS-CoV-2 and variants
Jun 14We Think Cocrystal Pharma (NASDAQ:COCP) Needs To Drive Business Growth Carefully
May 05Cocrystal Pharma updates on COVID-19 antiviral development programs
May 03Investors Who Bought Cocrystal Pharma (NASDAQ:COCP) Shares A Year Ago Are Now Up 94%
Mar 13What Is The Ownership Structure Like For Cocrystal Pharma, Inc. (NASDAQ:COCP)?
Jan 24Cocrystal sees 2021 cash burn of $800k a month
Jan 11Cocrystal Pharma to test CDI-45205 against coronaviruses
Dec 22Is Cocrystal Pharma (NASDAQ:COCP) In A Good Position To Invest In Growth?
Dec 20CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$627k | US$395k | -US$18m |
Sep 30 2023 | n/a | n/a | -US$18m |
Jun 30 2023 | n/a | n/a | -US$20m |
Mar 31 2023 | n/a | n/a | -US$40m |
Dec 31 2022 | US$622k | US$371k | -US$39m |
Sep 30 2022 | n/a | n/a | -US$38m |
Jun 30 2022 | n/a | n/a | -US$36m |
Mar 31 2022 | n/a | n/a | -US$16m |
Dec 31 2021 | US$665k | US$333k | -US$14m |
Sep 30 2021 | n/a | n/a | -US$12m |
Jun 30 2021 | n/a | n/a | -US$11m |
Mar 31 2021 | n/a | n/a | -US$10m |
Dec 31 2020 | US$462k | US$293k | -US$10m |
Sep 30 2020 | n/a | n/a | -US$56m |
Jun 30 2020 | n/a | n/a | -US$55m |
Mar 31 2020 | n/a | n/a | -US$53m |
Dec 31 2019 | US$241k | US$241k | -US$48m |
Sep 30 2019 | n/a | n/a | -US$45m |
Jun 30 2019 | n/a | n/a | -US$45m |
Mar 31 2019 | n/a | n/a | -US$45m |
Dec 31 2018 | US$412k | US$201k | -US$49m |
Sep 30 2018 | n/a | n/a | US$435k |
Jun 30 2018 | n/a | n/a | US$41k |
Mar 31 2018 | n/a | n/a | US$382k |
Dec 31 2017 | US$253k | US$253k | -US$613k |
Compensation vs Market: Sam's total compensation ($USD627.20K) is about average for companies of similar size in the US market ($USD677.87K).
Compensation vs Earnings: Sam's compensation has increased whilst the company is unprofitable.
CEO
Sam Lee (63 yo)
16.3yrs
Tenure
US$627,201
Compensation
Dr. Sam Lee, Ph D., Co-founded Cocrystal Pharma, Inc. in 2008 and serves as its President since January 2, 2014 and serves as its Interim Co-Chief Executive Officer since May 2023 and had been its Interim...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 4yrs | US$184.84k | 0.39% $ 62.1k | |
Co-Founder | 16.3yrs | US$627.20k | 0.36% $ 56.8k | |
Co-CEO, CFO & Corporate Secretary | 6.8yrs | US$627.20k | 0.000080% $ 12.7 |
16.3yrs
Average Tenure
63yo
Average Age
Experienced Management: COCP's management team is seasoned and experienced (16.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 4yrs | US$184.84k | 0.39% $ 62.1k | |
Independent Director | less than a year | US$49.47k | 9.98% $ 1.6m | |
Independent Director | 2.9yrs | US$44.23k | 0.033% $ 5.2k | |
Independent Director | 10.3yrs | US$84.12k | 12.97% $ 2.1m | |
Independent Vice Chairman | 10.3yrs | US$113.51k | 0.019% $ 3.1k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 5yrs | US$79.97k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | no data | no data |
4.5yrs
Average Tenure
76yo
Average Age
Experienced Board: COCP's board of directors are considered experienced (4.5 years average tenure).